Heron Therapeuti Stock Gross Profit

HRTX Stock

USD 2.32 0.09 3.73%

Heron Therapeuti fundamentals help investors to digest information that contributes to Heron Therapeuti's financial success or failures. It also enables traders to predict the movement of Heron Stock. The fundamental analysis module provides a way to measure Heron Therapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heron Therapeuti stock.

	Last Reported	Projected for Next Year
Gross Profit	105.6 M	110.9 M
Gross Profit Margin	0.73	0.52

Gross Profit is likely to rise to about 110.9 M in 2025, whereas Gross Profit Margin is likely to drop 0.52 in 2025.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Heron Therapeuti Company Gross Profit Analysis

Heron Therapeuti's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Heron Therapeuti Gross Profit

88.95 M

Most of Heron Therapeuti's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heron Therapeuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Heron Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for Heron Therapeuti is extremely important. It helps to project a fair market value of Heron Stock properly, considering its historical fundamentals such as Gross Profit. Since Heron Therapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heron Therapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heron Therapeuti's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.74	0.09	-0.63	0.69	0.49	1.0	0.39	0.36	-0.04	0.87	0.6	0.7	0.8	0.76	0.32	0.82	0.82	0.83	0.25
Total Stockholder Equity	0.74		-0.55	0.05	0.1	-0.23	0.78	0.32	0.14	-0.22	0.86	-0.08	0.17	0.99	0.13	0.08	0.32	0.91	0.91	-0.4
Net Debt	0.09	-0.55		-0.74	0.62	0.84	0.03	-0.32	0.11	0.31	-0.09	0.77	0.52	-0.47	0.64	-0.05	0.39	-0.24	-0.22	0.86
Retained Earnings	-0.63	0.05	-0.74		-0.89	-0.97	-0.57	-0.2	-0.28	-0.2	-0.27	-0.97	-0.83	-0.04	-0.97	-0.33	-0.85	-0.14	-0.16	-0.86
Net Receivables	0.69	0.1	0.62	-0.89		0.87	0.67	0.29	0.57	0.21	0.41	0.86	0.87	0.21	0.92	0.45	0.86	0.28	0.31	0.75
Total Liab	0.49	-0.23	0.84	-0.97	0.87		0.43	0.15	0.33	0.22	0.14	0.96	0.8	-0.14	0.92	0.35	0.77	0.0	0.02	0.88
Total Current Assets	1.0	0.78	0.03	-0.57	0.67	0.43		0.41	0.4	-0.06	0.89	0.54	0.67	0.83	0.71	0.32	0.79	0.85	0.86	0.2
Short Term Debt	0.39	0.32	-0.32	-0.2	0.29	0.15	0.41		0.53	-0.17	0.14	0.07	0.42	0.32	0.25	0.93	0.51	0.14	0.13	-0.08
Accounts Payable	0.36	0.14	0.11	-0.28	0.57	0.33	0.4	0.53		-0.06	0.25	0.2	0.47	0.19	0.34	0.66	0.44	0.16	0.2	0.12
Common Stock	-0.04	-0.22	0.31	-0.2	0.21	0.22	-0.06	-0.17	-0.06		-0.12	0.23	0.25	-0.18	0.15	-0.05	0.11	-0.11	-0.1	0.33
Short Term Investments	0.87	0.86	-0.09	-0.27	0.41	0.14	0.89	0.14	0.25	-0.12		0.26	0.43	0.9	0.43	0.01	0.51	0.96	0.97	-0.04
Property Plant Equipment	0.6	-0.08	0.77	-0.97	0.86	0.96	0.54	0.07	0.2	0.23	0.26		0.8	0.02	0.96	0.22	0.8	0.16	0.17	0.84
Current Deferred Revenue	0.7	0.17	0.52	-0.83	0.87	0.8	0.67	0.42	0.47	0.25	0.43	0.8		0.25	0.86	0.52	0.87	0.35	0.36	0.6
Net Tangible Assets	0.8	0.99	-0.47	-0.04	0.21	-0.14	0.83	0.32	0.19	-0.18	0.9	0.02	0.25		0.23	0.1	0.4	0.93	0.93	-0.29
Capital Surpluse	0.76	0.13	0.64	-0.97	0.92	0.92	0.71	0.25	0.34	0.15	0.43	0.96	0.86	0.23		0.35	0.89	0.32	0.34	0.76
Short Long Term Debt	0.32	0.08	-0.05	-0.33	0.45	0.35	0.32	0.93	0.66	-0.05	0.01	0.22	0.52	0.1	0.35		0.56	-0.03	-0.03	0.15
Long Term Debt Total	0.82	0.32	0.39	-0.85	0.86	0.77	0.79	0.51	0.44	0.11	0.51	0.8	0.87	0.4	0.89	0.56		0.41	0.42	0.61
Net Invested Capital	0.82	0.91	-0.24	-0.14	0.28	0.0	0.85	0.14	0.16	-0.11	0.96	0.16	0.35	0.93	0.32	-0.03	0.41		1.0	-0.2
Net Working Capital	0.83	0.91	-0.22	-0.16	0.31	0.02	0.86	0.13	0.2	-0.1	0.97	0.17	0.36	0.93	0.34	-0.03	0.42	1.0		-0.18
Capital Stock	0.25	-0.4	0.86	-0.86	0.75	0.88	0.2	-0.08	0.12	0.33	-0.04	0.84	0.6	-0.29	0.76	0.15	0.61	-0.2	-0.18

Click cells to compare fundamentals

Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Competition

Predict Heron Therapeuti

Gross Profit Over Time

According to the company disclosure, Heron Therapeuti reported 88.95 M of gross profit. This is 96.03% lower than that of the Biotechnology sector and 90.64% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.68% higher than that of the company.

Heron Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heron Therapeuti's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heron Therapeuti could also be used in its relative valuation, which is a method of valuing Heron Therapeuti by comparing valuation metrics of similar companies.

Heron Therapeuti is currently under evaluation in gross profit category among its peers.

Heron Therapeuti ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Heron Therapeuti's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Heron Therapeuti's managers, analysts, and investors.

Environmental

Governance

Social

Heron Fundamentals

	Return On Equity	-24.09
	Return On Asset	-0.0316
	Profit Margin	(0.09) %
	Operating Margin	0.10 %
	Current Valuation	472.65 M
	Shares Outstanding	152.33 M
	Shares Owned By Insiders	0.77 %
	Shares Owned By Institutions	76.80 %
	Number Of Shares Shorted	30.77 M
	Price To Earning	(5.15) X
	Price To Book	12.60 X
	Price To Sales	2.45 X
	Revenue	144.28 M
	Gross Profit	88.95 M
	EBITDA	(5.06 M)
	Net Income	(13.58 M)
	Cash And Equivalents	83.54 M
	Cash Per Share	0.81 X
	Total Debt	177.76 M
	Debt To Equity	6.64 %
	Current Ratio	1.77 X
	Book Value Per Share	(0.22) X
	Cash Flow From Operations	(22.53 M)
	Short Ratio	15.90 X
	Earnings Per Share	(0.09) X
	Price To Earnings To Growth	(0.18) X
	Target Price	6.0
	Number Of Employees	122
	Beta	1.55
	Market Capitalization	353.41 M
	Total Asset	233.15 M
	Retained Earnings	(1.92 B)
	Working Capital	117.56 M
	Current Asset	134.75 M
	Current Liabilities	19.73 M
	Net Asset	233.15 M

About Heron Therapeuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
CRM	Salesforce
CRM	Salesforce

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC